By enhancing PI3K/Akt signaling, GPR30 activation might promote glucose uptake in peripheral tissues and inhibit excessive gluconeogenesis, thereby mitigating hyperglycemia and insulin resistance associated with an HFD. Here, AKT1 is linked to Insulin resistance.